Clinical Trial Update: Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating prophylactic endoscopic variceal ligation to prevent variceal bleeding in patients with high-risk esophageal varices who are r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Varices
• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Asan Medical Center | Conditions: Hepatocellular Carcinoma, Esophageal Varix | Phase 2 | Status: RECRUITING